Highlights include leading application-based technologies, innovative
automation platforms and strategy award
PALM SPRINGS, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO), the world leader in serving science, is
showcasing a broad spectrum of laboratory automation capabilities, spanning
bench-top solutions to fully integrated platforms, at LabAutomation 2007.
These new technologies are designed to further improve workflow efficiency
and data reproducibility in two key areas of lab automation and drug
discovery research -- cell growth and analysis, and protein
crystallization.
"As customers continue to automate their work environment, we are
providing them with complete application-based technologies with an
emphasis on integrated workflows," said Marc N. Casper, executive vice
president of Thermo Fisher Scientific. "Today, we are more capable than
ever of improving and optimizing workflows for customers, with automation
and robotics solutions resulting from our larger portfolio of technologies
and platforms. By combining the latest instrumentation, robotics and
software, we can help our customers improve workflow efficiency and
maximize data acquisition and management."
At LabAutomation 2007, the company will highlight:
- Thermo Scientific Cell Growth and Discovery (CGD) WorkCell(TM):
Featuring the Cellomics ArrayScan imager, this automated cell culture
solution is the first preconfigured system to offer image analysis
technology. It is designed for high-capacity cell growth, supply and
in-line image analysis.
- Thermo Scientific MaX WorkCell(TM): The MaX WorkCell incorporates best-
in-class instrumentation to automate all plate preparation steps,
including screen making, drop setting and plate sealing. As part of the
Thermo Scientific Rhombix(TM) protein crystallization product series,
the MaX WorkCell is the only all-inclusive plate preparation system
available to customers today.
On display will be a number of additional technologies from Thermo
Fisher Scientific, most notably, the Thermo Scientific Matrix PlateMate
automated liquid-handler. This system can be easily integrated into other
robotic systems, including the Thermo Scientific CataLyst Express robot.
In addition, Frost & Sullivan has awarded Thermo Fisher Scientific the
"2006 Product Line Strategy Award" for its outstanding contribution to the
European laboratory automation market. The award acknowledges the
distinctive expertise of Thermo Fisher Scientific in advanced laboratory
automation solutions, its great insight into customer needs and its
market-leading ability to meet the ever-changing demands in drug discovery.
With a comprehensive range of technologies aimed at increasing workflow and
data management efficiency, Frost & Sullivan distinguishes Thermo Fisher
Scientific as a complete solutions provider.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, enabling our customers to make the world healthier,
cleaner and safer. With annual sales of more than $9 billion, we employ
30,000 people and serve over 350,000 customers within pharmaceutical and
biotech companies, hospitals and clinical diagnostic labs, universities,
research institutions and government agencies, as well as environmental and
industrial process control settings. Serving customers through two premier
brands, Thermo Scientific and Fisher Scientific, we help solve analytical
challenges from routine testing to complex research and discovery. Thermo
Scientific offers customers a complete range of high-end analytical
instruments as well as laboratory equipment, software, services,
consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of laboratory
equipment, chemicals, supplies and services used in healthcare, scientific
research, safety and education. Together, we offer the most convenient
purchasing options to customers and continuously advance our technologies
to accelerate the pace of scientific discovery, enhance value for customers
and fuel growth for shareholders and employees alike. Visit
http://www.thermofisher.com.
The following constitutes a "Safe Harbor" statement under the Private
Securities Litigation Reform Act of 1995: This press release contains
forward- looking statements that involve a number of risks and
uncertainties. Important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements include
those discussed in Thermo Electron and Fisher Scientific's Quarterly
Reports on Form 10-Q for the third quarter of 2006 under the caption "Risk
Factors," both of which are on file with the Securities and Exchange
Commission and available in the "Investors" section of our Website under
the heading "SEC Filings." We also may make forward-looking statements
about the benefits of the merger of Thermo Electron and Fisher Scientific,
including statements about future financial and operating results, the new
company's plans, objectives, expectations and intentions and other
statements that are not historical facts. Important factors that could
cause actual results to differ materially from those indicated by
forward-looking statements include risks and uncertainties relating to: the
risk that the businesses will not be integrated successfully; the risk that
the cost savings and any other synergies from the transaction may not be
fully realized or may take longer to realize than expected; disruption from
the transaction making it more difficult to maintain relationships with
customers, employees or suppliers; competition and its effect on pricing,
spending, third-party relationships and revenues; the need to develop new
products and adapt to significant technological change; implementation of
strategies for improving internal growth; use and protection of
intellectual property; dependence on customers' capital spending policies
and government funding policies; realization of potential future savings
from new productivity initiatives; dependence on customers that operate in
cyclical industries; general worldwide economic conditions and related
uncertainties; the effect of changes in governmental regulations; exposure
to product liability claims in excess of insurance coverage; and the effect
of exchange rate fluctuations on international operations. While we may
elect to update forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so, even if our estimates change
and, therefore, you should not rely on these forward-looking statements as
representing our views as of any date subsequent to today.
Media Contact Information:
Lori Gorski
Phone: 781-622-1242
E-mail: lori.gorski@thermofisher.com
Website: http://www.thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com
SOURCE Thermo Fisher Scientific Inc.
 back to top
Related links:
http://www.thermofisher.com/
http://www.prnewswire.com/comp/877850.html/
CONTACT:
Media, Lori Gorski, +1-781-622-1242, or
lori.gorski@thermofisher.com, or Investors, Ken Apicerno,
+1-781-622-1294, or ken.apicerno@thermofisher.com, both of Thermo
Fisher Scientific Inc.
|
